CAS NO: | 210344-97-1 |
规格: | ≥98% |
包装 | 价格(元) |
2mg | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
AA-Z-YVAD-FMK is a novel, cell-permeable, irreversible pan-caspase inhibitor with anti-inflammatory and anti-tumor activities. References: [1]. Li H1,et al.Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release.J Immunol. 2007 Apr 15;178(8):5271-6.
[2]. Avivi-Green C, et al. Different molecular events account for butyrate-induced apoptosis in two human colon cancer cell lines.J Nutr. 2002 Jul;132(7):1812-8.
[3]. Equils O, et al. Pretreatment with pancaspase inhibitor (Z-VAD-FMK) delays but does not prevent intraperitoneal heat-killed group B Streptococcus-induced preterm delivery in a pregnant mouse model.infect Dis Obstet Gynecol. 2009;2009:749432.
[4]. Künstle G,et al. ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha.Immunol Lett. 1997 Jan;55(1):5-10.
纯度:≥98%
CAS:210344-97-1